Application 202807
- Type
- ANDA
- Sponsor
- CATALENT
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NAPROXEN SODIUM | NAPROXEN SODIUM | CAPSULE;ORAL | EQ 200MG BASE | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0363-7510 | Naproxen Sodium | Naproxen Sodium | Walgreens | ANDA | Current |
| 0363-7510 | Naproxen Sodium | Naproxen Sodium | Walgreens | ANDA | Current |
| 55910-851 | Naproxen Sodium | Naproxen Sodium | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | ANDA | Current |
| 59726-751 | Naproxen Sodium | Naproxen Sodium | P & L Development, LLC | ANDA | Current |
| 59726-751 | Naproxen Sodium | Naproxen Sodium | P & L Development, LLC | ANDA | Current |